Lipoprotein lipase Lysate (NBL1-12656)

Lipoprotein lipase Lysate

100% Guarantee This product is fully covered under the Novus guarantee+ Policy. Click here for details.

Distributor Data...

Loading Ajax
Loading...
Loading...Unit Size: 0.1 mg
 
Bulk Request
Lipoprotein lipase Lysate Summary:
Applications:WB
Gene:LPL
Purity:Protein
Specificity:Homo sapiens lipoprotein lipase (LPL), mRNA.
 
Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
View Additional Lipoprotein lipase Products
Lipoprotein lipase Lysate Details:
Immunogen:The lysate was created in HEK293T cells, using plasmid ID RC203766 and based on accession number NM_000237. The protein contains a C-terminal DDK tag.
Lysate Details:
Type: OverexpressionLife Stage: Adult
Protein State: Native Tissue Condition: Normal
Sub-cellular Fraction: Whole
Applications:
Uses:This product is intended for use as a positive control in Western Blot. You will receive the lysate (100ug), and an empty vector negative control (100 ug).
Dilutions:Western Blot
TMW:50.3 kDa
Unit Size:0.1 mg
Concentration:1.0 mg/ml
Notes:
This product is manufactured by and sold under license from OriGene Technologies and its use is limited solely for research purposes. Please note that “1 mg/ml” refers to the total protein concentration and that the specific protein concentration is not determined at this time.
Packaging:
Storage:Store at -80 °C. Avoid freeze-thaw cycles.
Buffer:RIPA buffer
Limitations:This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Gene Symbol: LPL
Entrez4023 (Human)
Swiss ProtNM_000237 (Human)
 
Background:

LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

Jump to: Images, Ask a Question

Working with Lipoprotein lipase

Lipoprotein lipase Lysate Images (1)
Western Blot: Lipoprotein lipase Lysate [NBL1-12656] - Western Blot experiments. Left-Control; Right -Over-expression Lysate for LPL
Reviews (0)  Have you used this product? Review this product to earn Novus Rewards.

Ask a Scientist

Can't find an answer to your question about Lipoprotein lipase? Ask us by using live chat or by submitting your questions below:

 
Jump to: Lysates, Peptides and Proteins, Primary Antibodies, RNAi

Related Products

Lysates (2)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Lipoprotein lipase LysateH00004023-T01HuWB(2)

Peptides and Proteins
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Lipoprotein lipase Recombinant ProteinH00004023-P01HuELISA, WB(1)

Primary Antibodies (7)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Lipoprotein lipase AntibodyR-1346-100Bv, HuWB(1)

Lipoprotein lipase AntibodyNBP1-50735Hu, Mu, RtWB(1)

Lipoprotein lipase AntibodyH00004023-D01HuFunc, IP, WB

Lipoprotein lipase AntibodyNBP1-32215HuWB(1)

Lipoprotein lipase Antibody (2C5)NBP1-51565HuELISA, WB(1)

... and 2 more. See All »
RNAi (1)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Lipoprotein lipase RNAiH00004023-R01Hu(1)(4)


Jump to: Novus Explorer, Research Areas

Lipoprotein lipase in Context


Research Areas related to Lipoprotein lipase (1):
Novus Explorer for Lipoprotein lipase gene

Try our bioinformatic tool that shows the relationships between LPL and other genes, diseases, pathways and post-translational modifications.